Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Cervical Cancer, October 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 288 articles:
HTML format


 

Single Articles

  1. LI Q, Wang X, Liu J, Wu L, et al
    POT1 involved in telomeric DNA damage repair and genomic stability of cervical cancer cells in response to radiation.
    Mutat Res Genet Toxicol Environ Mutagen. 2023;891:503670.
    PubMed    
    Abstract available

  2. YUE S, Wang Q, Zhang J, Hu Q, et al
    Understanding cervical cancer at single-cell resolution.
    Cancer Lett. 2023 Sep 26:216408. doi: 10.1016/j.canlet.2023.216408.
    PubMed    
    Abstract available

  3. BREVIK TB, da Matta Calegari LR, Metcalfe IM, Laake P, et al
    Training health care providers to administer VIA as a screening test for cervical cancer: a systematic review of essential training components.
    BMC Med Educ. 2023;23:712.
    PubMed    
    Abstract available

  4. WAGNER GJ, Matovu JK, Juncker M, Namisango E, et al
    Knowledge Mediates the Effects of Game Changers for Cervical Cancer Prevention (GC-CCP) Intervention on Increased VIA Screening Advocacy in Uganda.
    Cancer Prev Res (Phila). 2023 Sep 28. doi: 10.1158/1940-6207.CAPR-23-0262.
    PubMed    
    Abstract available

  5. NAIR V, Dau H, Vidler M, AboMoslim M, et al
    Understanding the cervical cancer self-collection preferences of women living in urban and rural Rwanda.
    PLOS Glob Public Health. 2023;3:e0002135.
    PubMed    
    Abstract available

  6. YANG W, An L, Li Y, Qian S, et al
    A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification.
    Aging (Albany NY). 2023;15.
    PubMed    
    Abstract available

  7. YE Y, Zhang G, Li Z, Chen B, et al
    Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.
    Cancer Med. 2023 Sep 28. doi: 10.1002/cam4.6586.
    PubMed    
    Abstract available

  8. RAMIREZ AT, Valls J, Baena A, Rojas FD, et al
    Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study.
    Lancet Reg Health Am. 2023;26:100593.
    PubMed    
    Abstract available

  9. CI LQ, Huang ZG, Lv FM, Wang J, et al
    Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics 2019, 11, 15.
    Pharmaceutics. 2023;15:2188.
    PubMed    
    Abstract available

  10. ASHENAFI T, Stroetmann CY, Getachew S, Addissie A, et al
    Characteristics of Women Seeking Cervical Cancer Cytology Screening in a Private Health Facility.
    Medicina (Kaunas). 2023;59:1624.
    PubMed    
    Abstract available

  11. BIANCHI T, Grassi T, Bazzurini L, Di Martino G, et al
    Radical Hysterectomy in Early-Stage Cervical Cancer: Abandoning the One-Fits-All Concept.
    J Pers Med. 2023;13:1292.
    PubMed    
    Abstract available

  12. WATKINS DE, Craig DJ, Vellani SD, Hegazi A, et al
    Advances in Targeted Therapy for the Treatment of Cervical Cancer.
    J Clin Med. 2023;12:5992.
    PubMed    
    Abstract available

  13. CHUA B, Lim LM, Ng JSY, Ma Y, et al
    Correction: Chua et al. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. Cancers 2023, 15, 1812.
    Cancers (Basel). 2023;15:4658.
    PubMed    
    Abstract available

  14. CHEUNG ES, Law FC, Fung NT, Soong IS, et al
    Simultaneous Integrated Boost for Dose Escalation in Node-Positive Cervical Cancer: 5-Year Experience in a Single Institution.
    Cancers (Basel). 2023;15:4647.
    PubMed    
    Abstract available

  15. DENNY L, Saidu R, Boa R, Mbatani N, et al
    Point-of-care testing with Xpert HPV for single-visit, screen-and-treat for cervical cancer prevention: a demonstration study in South Africa.
    Sci Rep. 2023;13:16182.
    PubMed    
    Abstract available

  16. EGEMEN D, Perkins RB, Cheung LC, Befano B, et al
    AI-based image analysis in clinical testing: lessons from cervical cancer screening.
    J Natl Cancer Inst. 2023 Sep 27:djad202. doi: 10.1093.
    PubMed    
    Abstract available

  17. HOBENU KA, Naab F
    A qualitative exploration of the spiritual wellbeing of women with advanced cervical cancer in Ghana.
    Int J Palliat Nurs. 2023;29:434-444.
    PubMed    
    Abstract available

  18. SHU Q, He X, Chen X, Liu M, et al
    Head-to-Head Comparison of 18F-FDG and 68Ga-FAPI-04 PET/CT for Radiological Evaluation of Cervical Cancer.
    Clin Nucl Med. 2023 Sep 19. doi: 10.1097/RLU.0000000000004833.
    PubMed    
    Abstract available

  19. LI J, Chen S, Wu J, Liu X, et al
    Pathogenomics model for personalized medicine in cervical cancer: Cross-talk of gene expressions and pathological images related to oxidative stress.
    Environ Toxicol. 2023 Sep 26. doi: 10.1002/tox.23974.
    PubMed    
    Abstract available

  20. YADAV N, Singh M, Mishra SP, Ansari S, et al
    Development of an Anthropomorphic Heterogeneous Female Pelvic Phantom and Its Comparison with a Homogeneous Phantom in Advance Radiation Therapy: Dosimetry Analysis.
    Med Sci (Basel). 2023;11:59.
    PubMed    
    Abstract available

  21. KHAN S, Sheikh T, Castro G, Barengo NC, et al
    Effect Modification of Race on the Associated Tumor Size at Diagnosis and 10-Year Cancer Survival Rates in Women with Cervical Squamous Cell Carcinoma in the United States.
    Int J Environ Res Public Health. 2023;20:6742.
    PubMed    
    Abstract available

  22. ALMOMEN A, Badran M, Alhowyan AA, Alkholief M, et al
    Imiquimod-Loaded Chitosan-Decorated Di-Block and Tri-Block Polymeric Nanoparticles Loaded In Situ Gel for the Management of Cervical Cancer.
    Gels. 2023;9:713.
    PubMed    
    Abstract available

  23. TANG B, Dou S
    Knockdown of PAF1 reduces cervical cancer cell proliferation, migration and invasion via retarding FLOT2-mediated MEK/ERK1/2 pathway.
    Cell Adh Migr. 2023;17:1-10.
    PubMed    
    Abstract available

  24. MULCAHY SYMMONS S, Leavy P, Heavey L, Mason Mohan C, et al
    How is equity captured for colorectal, breast and cervical cancer incidence and screening in the Republic of Ireland: A review.
    Prev Med Rep. 2023;36:102405.
    PubMed    
    Abstract available

  25. WANG L, Yi S, Teng Y, Li W, et al
    Role of the tumor microenvironment in the lymphatic metastasis of cervical cancer (Review).
    Exp Ther Med. 2023;26:486.
    PubMed    
    Abstract available

  26. LI J, Wang Y, Huo L, Huang X, et al
    Definitive irradiation as a first treatment strategy for primary and metastatic sites of newly diagnosed IVB cervical cancer that presented with synchronous oligometastases.
    Radiat Oncol. 2023;18:159.
    PubMed    
    Abstract available

  27. LIU L, Deng X, Guo S, Yang S, et al
    Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature.
    Diagn Pathol. 2023;18:107.
    PubMed    
    Abstract available

  28. ALIFU N, Ma R, Zhu L, Du Z, et al
    Retraction: A novel TMTP1-modified theranostic nanoplatform for targeted in vivo NIR-II fluorescence imaging-guided chemotherapy for cervical cancer.
    J Mater Chem B. 2023 Sep 26. doi: 10.1039/d3tb90178.
    PubMed    
    Abstract available

  29. WANG M, Li Z
    Prediction of prognosis and immune landscape in cervical cancer based on heat shock protein-related genes.
    Int J Hyperthermia. 2023;40:2259140.
    PubMed    
    Abstract available

  30. MCGINNIS JM, Pond GR, Reade CJ, Schnarr KL, et al
    Evaluating equity of access and predictors of minimally invasive hysterectomy for endometrial and cervical cancer from 2000 to 2017 in Ontario, Canada: A population-based cohort study.
    J Surg Oncol. 2023 Sep 26. doi: 10.1002/jso.27461.
    PubMed    
    Abstract available

  31. KUTZ JM, Rausche P, Rasamoelina T, Ratefiarisoa S, et al
    Female genital schistosomiasis, human papilloma virus infection, and cervical cancer in rural Madagascar: a cross sectional study.
    Infect Dis Poverty. 2023;12:89.
    PubMed    
    Abstract available

  32. BECERRA-CANALES B, Campos M, Atuncar-Deza S, Caceres-Yparraguirre H, et al
    Prevalence and factors associated with cervical cancer preventive screening in a Peruvian region.
    Medwave. 2023;23.
    PubMed    
    Abstract available

  33. TABRIZI-NEZHADI P, MotieGhader H, Maleki M, Sahin S, et al
    Application of Protein-Protein Interaction Network Analysis in Order to Identify Cervical Cancer miRNA and mRNA Biomarkers.
    ScientificWorldJournal. 2023;2023:6626279.
    PubMed    
    Abstract available

  34. ZRAIDI M, Ibriz M
    Human papillomavirus vaccination in view of the National Cancer Control Plan 2020-2029 in Morocco.
    Pan Afr Med J. 2023;45:115.
    PubMed    
    Abstract available

  35. ZRAIDI M, Ibriz M
    [Epidemiological and clinical profile of cervical cancer in Morocco: cases in the Gharb region].
    Pan Afr Med J. 2023;45:114.
    PubMed    


  36. LIU X, Wang CX, Feng Q, Zhang T, et al
    lncRNA TINCR promotes the development of cervical cancer via the miRNA?7/mTOR axis in vitro.
    Exp Ther Med. 2023;26:487.
    PubMed    
    Abstract available

  37. LI X, Zhang X, Li A, Xie P, et al
    Editorial: The role of maintenance therapy (immunotherapy, targeted therapy, etc) in cancer control and biologic behavior of recurrent/metastatic cervical cancer.
    Front Immunol. 2023;14:1281775.
    PubMed    


  38. BACORRO W, Olonan BN, Co HC, Fineza-Dela Cruz AM, et al
    Challenges and opportunities in the implementation of advanced brachytherapy programs for cervical cancer in the Philippines.
    Asia Pac J Clin Oncol. 2023 Sep 24. doi: 10.1111/ajco.14012.
    PubMed    
    Abstract available

  39. PHAN NTH, Tran QT, Nguyen NPT, Nguyen HT, et al
    Erratum: Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium.
    J Gynecol Oncol. 2023 Sep 18. doi: 10.3802/jgo.2023.
    PubMed    
    Abstract available

  40. ABAH AU, Omokhapue A, Adewole A, Usifoh N, et al
    Environmental and psychosocial predictors of cervical cancer screening among women in Gwagwalada Area Council, Abuja, North Central, Nigeria.
    Afr J Reprod Health. 2023;27:32-42.
    PubMed    
    Abstract available

  41. JOLLY PE, Junkins A, Aung M
    Sociodemographic characteristics, attitudes, and knowledge associated with previous screening for cervical cancer among women in western Jamaica.
    Infect Agent Cancer. 2023;18:53.
    PubMed    
    Abstract available

  42. QU N, Meng Y, Zhai J, Griffin N, et al
    Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b(+) NCR1(+) NKs of tumor microenvironment.
    Int Immunopharmacol. 2023;124.
    PubMed    
    Abstract available

  43. SHENG B, Wang W, Xia D, Qu X, et al
    Panobinostat (LBH589) combined with AM1241 induces cervical cancer cell apoptosis through autophagy pathway.
    BMC Pharmacol Toxicol. 2023;24:45.
    PubMed    
    Abstract available

  44. KASSYMBEKOVA F, Zhetpisbayeva I, Tcoy E, Dyussenov R, et al
    Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: a mixed-methods study protocol.
    BMJ Open. 2023;13:e074097.
    PubMed    
    Abstract available

  45. ZHAO XL, Hu SY, Hu JW, Wang HH, et al
    Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward.
    Infect Dis Poverty. 2023;12:86.
    PubMed    
    Abstract available

  46. JI J, Zhang W, Dong Y, Lin R, et al
    Automated cervical cell segmentation using deep ensemble learning.
    BMC Med Imaging. 2023;23:137.
    PubMed    
    Abstract available

  47. SCHIMUNEK L, Schopp K, Wagner M, Brucker SY, et al
    Hyperspectral imaging as a new diagnostic tool for cervical intraepithelial neoplasia.
    Arch Gynecol Obstet. 2023;308:1525-1530.
    PubMed    
    Abstract available

  48. BIEHL R, Efre A
    Improving human papilloma virus vaccination rates among adolescents.
    J Am Assoc Nurse Pract. 2023;35:642-645.
    PubMed    
    Abstract available

  49. MINAMITANI M, Mukai T, Tatemichi M, Katano A, et al
    [A report of five cancer screening rates and the related measures for cancer control in the workplace, surveyed by the Corporate Action to Promote Cancer Control].
    Sangyo Eiseigaku Zasshi. 2023;65:231-247.
    PubMed    
    Abstract available

  50. CHEN X, Aljrees T, Umer M, Saidani O, et al
    Cervical cancer detection using K nearest neighbor imputer and stacked ensemble learningmodel.
    Digit Health. 2023;9:20552076231203802.
    PubMed    
    Abstract available

  51. METHODS IN MEDICINE CAM
    Retracted: Effect of Comprehensive Care Based on Appropriate Chinese Medicine Techniques on Urinary Retention and Bladder Function Recovery after Total Hysterectomy in Patients with Cervical Cancer.
    Comput Math Methods Med. 2023;2023:9761425.
    PubMed    
    Abstract available

  52. SAWADA M, Shiraishi Y, Toyama H, Tanaka T, et al
    Dosimetric comparison of rectal dose-reductive techniques in intra-cavitary brachytherapy for cervical cancer: A retrospective analysis.
    J Contemp Brachytherapy. 2023;15:269-274.
    PubMed    
    Abstract available

  53. ELMALI A, Biltekin F, Sari SY, Gultekin M, et al
    Inter-observer variation of target volume delineation for CT-guided cervical cancer brachytherapy.
    J Contemp Brachytherapy. 2023;15:253-260.
    PubMed    
    Abstract available

  54. GROSSMANN LM, Napierala H, Herrmann WJ
    Differences in breast and cervical cancer screening between West and East Germany: a secondary analysis of a german nationwide health survey.
    BMC Public Health. 2023;23:1931.
    PubMed    
    Abstract available

  55. FLEMING GF
    Flashback Foreword: Concurrent Chemotherapy/Radiotherapy for Cervical Cancer.
    J Clin Oncol. 2023;41:4603-4604.
    PubMed    


  56. WANG X, Shuai G, Xu J, Liu M, et al
    HPV16 E7 oncoprotein test as a triage strategy for HPV16-positive women in cervical cancer screening: long-term follow-up outcome.
    Front Oncol. 2023;13:1221962.
    PubMed    
    Abstract available

  57. WANG Y, Chen Y, Wang M, Qin Z, et al
    Oncological and reproductive outcomes of conization combined with pelvic node evaluation in patients with early-stage cervical cancer: a systematic review and meta-analysis.
    Front Oncol. 2023;13:1251453.
    PubMed    
    Abstract available

  58. MAURO GP, de Aquino Calheiros V, Vonsowski MS, Avelar T, et al
    Curative treatment for stage IIIC2 cervical cancer: what to expect?
    Rep Pract Oncol Radiother. 2023;28:332-339.
    PubMed    
    Abstract available

  59. QU X, Wang Y, Jiang Q, Ren T, et al
    Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3(+) dendritic cells with CD4(+) regulatory T cells and CD8(+) exhausted T cells: synergistically remodeling of the immunosuppressive microenvironment in cervical cancer and therapeutic implic
    Cancer Commun (Lond). 2023 Oct 4. doi: 10.1002/cac2.12486.
    PubMed    
    Abstract available

  60. SIVARS L, Holzhauser S, Ramqvist T, Tham E, et al
    Prevalence of human papillomavirus (HPV) types 16 and 18 in cervical cancer in Stockholm, Sweden during 2019-2023 compared to 2003-2008.
    Acta Oncol. 2023 Oct 4:1-4. doi: 10.1080/0284186X.2023.2264485.
    PubMed    
    Abstract available

  61. XU L, Tan Y, Xiang P, Luo Y, et al
    Diet-Related Risk Factors for Cervical Cancer: Data from National Health and Nutrition Examination Survey 1999-2018.
    Nutr Cancer. 2023 Oct 4:1-8. doi: 10.1080/01635581.2023.2261649.
    PubMed    
    Abstract available

  62. AGOSTINELLI V, Musacchio L, Camarda F, Salutari V, et al
    Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data.
    Cancer Manag Res. 2023;15:1063-1072.
    PubMed    
    Abstract available

  63. MORSE RM, Brown J, Gage JC, Prieto BA, et al
    "Easy women get it": Pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program.
    Res Sq. 2023 Sep 11:rs.3.rs-3256535. doi: 10.21203/rs.3.rs-3256535.
    PubMed    
    Abstract available

  64. JALLAH JK, Anjankar A, Nankong FA
    Public Health Approach in the Elimination and Control of Cervical Cancer: A Review.
    Cureus. 2023;15:e44543.
    PubMed    
    Abstract available

  65. KEDIA M, Khatun S, Phukon U, Shankar B, et al
    Trinuclear rhenium(I)-based metallocages as anticancer agents towards human cervical cancer cells.
    Dalton Trans. 2023 Oct 4. doi: 10.1039/d3dt02535.
    PubMed    
    Abstract available

  66. DE HOND YJM, van Haaren PMA, Verrijssen AE, Tijssen RHN, et al
    Inter-observer variability in library plan selection on iterative CBCT and synthetic CT images of cervical cancer patients.
    J Appl Clin Med Phys. 2023 Oct 3:e14170. doi: 10.1002/acm2.14170.
    PubMed    
    Abstract available

  67. SINGH N, Rajput S, Jaiswar SP
    Correlation of menstrual hygiene management with cervical intraepithelial neoplasia and cervical cancer.
    J Cancer Res Ther. 2023;19:1148-1152.
    PubMed    
    Abstract available

  68. DIAKITE I, Kyle J, Situ S, Bai P, et al
    Public health impact of 2-, 4-, and 9-valent HPV vaccination in females on cervical and noncervical diseases in men and women under different coverage scenarios in China: A simulation study.
    Hum Vaccin Immunother. 2023;19:2258569.
    PubMed    
    Abstract available

  69. CIBI A, Rose RJ
    Classification of stages in cervical cancer MRI by customized CNN and transfer learning.
    Cogn Neurodyn. 2023;17:1261-1269.
    PubMed    
    Abstract available

  70. MUTHAMILSELVAN S, Palaniappan A
    CESCProg: a compact prognostic model and nomogram for cervical cancer based on miRNA biomarkers.
    PeerJ. 2023;11:e15912.
    PubMed    
    Abstract available

  71. FITCH KC, Nguyen CGT, Vasquez Guzman CE, Holmes RS, et al
    Persistent cervical cancer disparities among American Indian/Alaska Native women: a systematic scoping review exploring the state of the science in this population.
    Cancer Causes Control. 2023 Oct 3. doi: 10.1007/s10552-023-01799.
    PubMed    
    Abstract available

  72. AKASH S, Bayil I, Hossain MS, Islam MR, et al
    Novel computational and drug design strategies for inhibition of human papillomavirus-associated cervical cancer and DNA polymerase theta receptor by Apigenin derivatives.
    Sci Rep. 2023;13:16565.
    PubMed    
    Abstract available

  73. LIU X, Liu Z, Liu Y, Wang N, et al
    ATG9A modulated by miR-195-5p can boost the malignant progression of cervical cancer cells.
    Epigenetics. 2023;18:2257538.
    PubMed    
    Abstract available

  74. KABUKYE JK, Namugga J, Mpamani CJ, Katumba A, et al
    Implementing Smartphone-Based Telemedicine for Cervical Cancer Screening in Uganda: Qualitative Study of Stakeholders' Perceptions.
    J Med Internet Res. 2023;25:e45132.
    PubMed    
    Abstract available

  75. ORJI AF, Roess AA
    Assessing Disparities in Cervical Cancer Screening with Pap Test by Disability Types.
    J Cancer Educ. 2023 Oct 2. doi: 10.1007/s13187-023-02373.
    PubMed    
    Abstract available

  76. AMENGUAL VILA J, Torrent Colomer A, Sampol Bas C, Quintero Duarte A, et al
    A hybrid approach: a safe option for surgical treatment of early-stage cervical cancer.
    Eur Rev Med Pharmacol Sci. 2023;27:8905-8914.
    PubMed    
    Abstract available

  77. AVCI F, Kulhan M, Guler AH, Ates MC, et al
    Lymph node size detected by magnetic resonance imaging for prediction of lymph node involvement in locally advanced cervical cancer.
    Eur Rev Med Pharmacol Sci. 2023;27:8889-8894.
    PubMed    
    Abstract available

  78. ZHAO YC, Wang TJ, She LZ, Cui J, et al
    S100A10 Overexpression Correlates with Adverse Prognosis, Tumor Microenvironment, and Aggressive Behavior In Vitro and In Vivo of Cervical Cancer.
    J Cancer. 2023;14:2931-2945.
    PubMed    
    Abstract available

  79. HERSHKOVITZ G, Ochshorn Y, Michaan N, Fiszer E, et al
    Knowledge is power? Cervical cancer prevention in female OB/GYNs compared to other female physicians.
    Front Public Health. 2023;11:1269393.
    PubMed    
    Abstract available

  80. DABAN-LOPEZ P, Fernandez-Martinez NF, Petrova D, Rodriguez-Barranco M, et al
    Epidemiology of human papillomavirus-associated anogenital cancers in Granada: a three-decade population-based study.
    Front Public Health. 2023;11:1205170.
    PubMed    
    Abstract available

  81. LUBEYA MK, Chibwesha CJ, Mwanahamuntu M, Mukosha M, et al
    "When you get the HPV vaccine, it will prevent cervical cancer; it will act as a shield": adolescent girls' knowledge and perceptions regarding the human papillomavirus vaccine in Zambia.
    Front Health Serv. 2023;3:1208458.
    PubMed    
    Abstract available

  82. KERR L, Bourne A, Hill AO, McNair R, et al
    Cervical screening among LGBTQ people: how affirming services may aid in achieving cervical cancer elimination targets.
    Women Health. 2023 Oct 1:1-11. doi: 10.1080/03630242.2023.2263594.
    PubMed    
    Abstract available

  83. LIU C, Zhou L, Chen J, Yang Z, et al
    Galectin-7 promotes cisplatin efficacy by facilitating apoptosis and G3BP1 degradation in cervical cancer.
    Biochem Pharmacol. 2023 Sep 29:115834. doi: 10.1016/j.bcp.2023.115834.
    PubMed    
    Abstract available

  84. PAUL A, Sarker S, Banik BC, Paul A, et al
    Detection of Oncogenic Human Papillomavirus (HPV-16 and HPV-18) from Bacterial Vaginosis Positive Patient Attending at Tertiary Care Hospital in Mymensingh.
    Mymensingh Med J. 2023;32:959-967.
    PubMed    
    Abstract available

  85. WUBU A, Balta B, Cherie A, Bizuwork K, et al
    Perception about human papillomavirus vaccination among middle adolescent school girls in Addis Ababa, Ethiopia 2023: qualitative study.
    BMC Womens Health. 2023;23:520.
    PubMed    
    Abstract available

  86. BENARD E, Drolet M, Laprise JF, Gingras G, et al
    Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis.
    Lancet Public Health. 2023;8:e788-e799.
    PubMed    
    Abstract available

  87. HARPER DM, O'Dwyer MC
    One less dose of HPV vaccine to prevent cancer.
    Lancet Public Health. 2023;8:e748-e749.
    PubMed    


  88. KASSA R, Irene Y, Woldetsadik E, Kidane E, et al
    Survival of women with cervical cancer in East Africa: a systematic review and meta-analysis.
    J Obstet Gynaecol. 2023;43:2253308.
    PubMed    
    Abstract available

  89. MARTINEZ-ESQUIVIAS F, Guzman-Flores JM, Chavez-Diaz IF, Iniguez-Munoz LE, et al
    Pharmacological network study on the effect of 6-gingerol on cervical cancer using computerized databases.
    J Biomol Struct Dyn. 2023 Sep 29:1-12. doi: 10.1080/07391102.2023.2264943.
    PubMed    
    Abstract available

  90. CARICATO P, Trivellato S, Pellegrini R, Montanari G, et al
    Updating approach for lexicographic optimization-based planning to improve cervical cancer plan quality.
    Discov Oncol. 2023;14:180.
    PubMed    
    Abstract available

  91. SHAO R, Qiao X, Cao L, Man J, et al
    Multimodal imaging and photothermal/chemodynamic therapy of cervical cancer using GSH-responsive MoS(2)@MnO(2) theranostic nanoparticles.
    Discov Nano. 2023;18:122.
    PubMed    
    Abstract available

  92. HERWEIJER E, Wang J, Hu K, Valdimarsdottir UA, et al
    Overall and Cervical Cancer Survival in Patients With and Without Mental Disorders.
    JAMA Netw Open. 2023;6:e2336213.
    PubMed    
    Abstract available

  93. ZHANG D, Zhang S, He Z, Chen Y, et al
    Cytosine-phosphate-guanine oligodeoxynucleotides alleviate radiation-induced kidney injury in cervical cancer by inhibiting DNA damage and oxidative stress through blockade of PARP1/XRCC1 axis.
    J Transl Med. 2023;21:679.
    PubMed    
    Abstract available

  94. MENG H, Guo X, Zhang D
    Multimodal magnetic resonance imaging in the diagnosis of cervical cancer and its correlation with the differentiation process of cervical cancer.
    BMC Med Imaging. 2023;23:144.
    PubMed    
    Abstract available

  95. DIAO W, Zhu C, Guo Q, Cao Y, et al
    [Retracted] Tripartite motif?containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway.
    Mol Med Rep. 2023;28:213.
    PubMed    
    Abstract available

  96. MARTINELLI M, Giubbi C, Di Meo ML, Perdoni F, et al
    Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy.
    Viruses. 2023;15:1889.
    PubMed    
    Abstract available

  97. TAMPAKOUDIS G, Anastasiou OE
    Burden of HPV-Related Hospitalization in Germany from 2000 to 2021.
    Viruses. 2023;15:1857.
    PubMed    
    Abstract available

  98. CHEN Y, Wu D
    Cervical ulcer caused by group B streptococcus with bacterial vaginosis: a case report.
    BMC Womens Health. 2023;23:516.
    PubMed    
    Abstract available

  99. LI T, Yang Z, Zhang C, Wang S, et al
    Genetic variation of E6 and E7 genes of human papillomavirus type 16 from central China.
    Virol J. 2023;20:217.
    PubMed    
    Abstract available

  100. JAFARI B, Gholizadeh E, Jafari B, Zhoulideh M, et al
    Highly sensitive label-free biosensor: graphene/CaF(2) multilayer for gas, cancer, virus, and diabetes detection with enhanced quality factor and figure of merit.
    Sci Rep. 2023;13:16184.
    PubMed    
    Abstract available

  101. XIAO X, Cao Y, Bi K, Wang W, et al
    The Triaging Effect of the Human Papillomavirus 16/18 E7 Oncoprotein Assay in HPV 16/18-Positive Patients for High-Grade Cervical Intraepithelial Neoplasia Screening: A Cross-Sectional Study.
    J Womens Health (Larchmt). 2023;32:1136-1141.
    PubMed    
    Abstract available

  102. KOIKE R, Yunokawa M, Omatsu K, Kurihara N, et al
    Retrospective study of the efficacy and safety of docetaxel/carboplatin combination therapy as postoperative adjuvant chemotherapy for nonsquamous cell carcinoma of the cervix.
    Int J Clin Oncol. 2023;28:1421-1430.
    PubMed    
    Abstract available

  103. BEAVERSON S, Cyrus JW, Huffstetler AN
    Concordance of Primary Human Papillomavirus Testing Among Clinicians and Patients: A Systematic Review.
    J Womens Health (Larchmt). 2023;32:1062-1072.
    PubMed    
    Abstract available

  104. BERRY WCE, Capbarat EV, Walker TV, Rosenberg SF, et al
    Associations between gynecologic clinician type and routine female sexual dysfunction screening.
    J Sex Med. 2023;20:1235-1240.
    PubMed    
    Abstract available

  105. TOURNAIRE M, Gondry J, Mauny L, Devouche E, et al
    Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening.
    J Gynecol Obstet Hum Reprod. 2023;52:102630.
    PubMed    
    Abstract available

  106. TOROUS VF
    Cervicovaginal Papanicolaou tests in transgender men: Cytomorphologic alterations, interpretation considerations, and clinical implications.
    Cancer Cytopathol. 2023;131:626-636.
    PubMed    
    Abstract available

  107. NAKAJIMA Y, Iwasaki E, Kayashima A, Machida Y, et al
    Successful radiotherapy for recurrent obstructive pancreatitis secondary to pancreatic metastasis from cervical squamous-cell carcinoma.
    Clin J Gastroenterol. 2023;16:755-760.
    PubMed    
    Abstract available

  108. HU J, Tang L, Wang C, Zhang D, et al
    A rare case of cervical mesonephric adenocarcinoma with right femur metastasis.
    Asian J Surg. 2023;46:4639-4640.
    PubMed    


  109. GERIS JM, Amirian ES, Marquez-Do DA, Guillaud M, et al
    Polymorphisms in the Nonhomologous End-joining DNA Repair Pathway are Associated with HPV Integration in Cervical Dysplasia.
    Cancer Prev Res (Phila). 2023;16:461-469.
    PubMed    
    Abstract available

  110. HU J, Xiao Y, Liu Y, Zhang D, et al
    A rare case of primary isolated myeloid sarcoma arising at the uterine cervix.
    Asian J Surg. 2023;46:4533-4535.
    PubMed    


  111. CHEN G, Zheng Z, Sun H, You J, et al
    Dedifferentiated Schwann cells promote perineural invasion mediated by the PACAP paracrine signalling in cervical cancer.
    J Cell Mol Med. 2023 Oct 13. doi: 10.1111/jcmm.17897.
    PubMed    
    Abstract available

  112. AND ALTERNATIVE MEDICINE EC
    Retracted: The Influence of Family-Oriented Enabling Psychological Nursing on Posttraumatic Stress and Fear of Recurrence in Patients with Cervical Cancer.
    Evid Based Complement Alternat Med. 2023;2023:9806573.
    PubMed    
    Abstract available

  113. YOSHIKAWA N, Itoh Y, Matsukawa T, Kawamura M, et al
    Local hyperthermia with built-in endoscopy for radioresistant cervical cancer: a case series.
    Nagoya J Med Sci. 2023;85:639-647.
    PubMed    
    Abstract available

  114. HEALTHCARE ENGINEERING JO
    Retracted: Effects of Continuous Catheterization on Reducing Postoperative Urinary Tract Infection in Cervical Cancer Patients with Double J Stent Placement.
    J Healthc Eng. 2023;2023:9797565.
    PubMed    
    Abstract available

  115. DU JQ, Zhang F, Wang CQ, Zhu JF, et al
    Effects of peripheral blood neutrophil/lymphocyte ratio levels and their changes on the prognosis of patients with early cervical cancer.
    Front Oncol. 2023;13:1139809.
    PubMed    
    Abstract available

  116. JIA X, Zhou J, Fu Y, Ma C, et al
    Establishment of prediction models to predict survival among patients with cervical cancer based on socioeconomic factors: a retrospective cohort study based on the SEER Database.
    BMJ Open. 2023;13:e072556.
    PubMed    
    Abstract available

  117. WANG Y, Zhao J, Wu J, Liu J, et al
    Genome-wide perturbations of A-to-I RNA editing dysregulated circular RNAs promoting the development of cervical cancer.
    Comput Biol Med. 2023;166:107546.
    PubMed    
    Abstract available

  118. BATMAN S, Rangeiro R, Monteiro E, Changule D, et al
    Expanding Cervical Cancer Screening in Mozambique: Challenges Associated With Diagnosing and Treating Cervical Cancer.
    JCO Glob Oncol. 2023;9:e2300139.
    PubMed    
    Abstract available

  119. JELIC M, Mandic A, Maricic S, Bozin B, et al
    PREDICTIVE POWER OF OXIDATIVE STRESS BIOMARKERS IN RECURRENCE AND SURVIVAL IN ADVANCED CERVICAL CANCER.
    Exp Oncol. 2023;45:231-241.
    PubMed    
    Abstract available

  120. MARTELLO G, Gori S, Frayle H, Franceschi S, et al
    Acceptability of deferring the start of cervical cancer screening to age 30 for women vaccinated against human papillomavirus.
    Prev Med Rep. 2023;36:102438.
    PubMed    
    Abstract available

  121. LI J, Zhou H, Lu X, Wang Y, et al
    Preoperative prediction of cervical cancer survival using a high-resolution MRI-based radiomics nomogram.
    BMC Med Imaging. 2023;23:153.
    PubMed    
    Abstract available

  122. SANTANA EO, Silva LDS, Silva LAAD, Lemos JLA, et al
    Effect of guided imagery relaxation on anxiety in cervical cancer: randomized clinical trial.
    Rev Bras Enferm. 2023;76:e20210874.
    PubMed    
    Abstract available

  123. MA Y, Yang QQ, Gu DM, Yuan X, et al
    Canadine inhibits epithelial mesenchymal transformation of HPV-negative cervical cancer.
    Tissue Barriers. 2023 Oct 11:2256641. doi: 10.1080/21688370.2023.2256641.
    PubMed    
    Abstract available

  124. CHEN X, Hao Y, Liu Y, Zhong S, et al
    NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer.
    Adv Sci (Weinh). 2023 Oct 11:e2302705. doi: 10.1002/advs.202302705.
    PubMed    
    Abstract available

  125. HUANG Q, Li S, Chen X, He C, et al
    Association between serum lactate dehydrogenase and lymph node metastasis in cervical cancer.
    Oncol Lett. 2023;26:482.
    PubMed    
    Abstract available

  126. YANG H, Sun Y, Jia X, Cai Y, et al
    TBX3 promotes the epithelial mesenchymal transition of cervical cancer by upregulating ID1.
    Am J Cancer Res. 2023;13:4115-4124.
    PubMed    
    Abstract available

  127. HAN L, Chen Y, Zheng A, Tan X, et al
    Minimally invasive versus abdominal radical trachelectomy for early-stage cervical cancer: a systematic review and meta-analysis.
    Am J Cancer Res. 2023;13:4466-4477.
    PubMed    
    Abstract available

  128. YADAV A, Yadav S, Alam MA
    Immunotherapies landscape and associated inhibitors for the treatment of cervical cancer.
    Med Oncol. 2023;40:328.
    PubMed    
    Abstract available

  129. YI J, Li X, Zhang R, Kong L, et al
    The impact of the COVID-19 pandemic on the prevalence and genotype distribution of HPV infection in Beijing, China.
    J Med Virol. 2023;95:e29155.
    PubMed    
    Abstract available

  130. LIU H, Rao Y, Sun C, Wang Y, et al
    [Changes of brain network in patients with insomnia following radiotherapy for cervical cancer and their correlation with IT-TMS treatment efficacy: a graph-theory analysis].
    Nan Fang Yi Ke Da Xue Xue Bao. 2023;43:1629-1635.
    PubMed    
    Abstract available

  131. OLIUSHINA EM, Zavalishina LE, Andreeva YY, Kuznetsova OA, et al
    [Predictive markers of immunotherapy in cervical cancer].
    Arkh Patol. 2023;85:5-12.
    PubMed    
    Abstract available

  132. DENG S, Welby S, Liu Z, Yang Y, et al
    MOnitoring human papillomavirus Vaccine effect on Infection and cErvical diseases (MOVIE): Protocol for a cohort study using electronic health records from Yinzhou, China.
    Hum Vaccin Immunother. 2023;19:2257989.
    PubMed    
    Abstract available

  133. SARWAR KA, Hussain S, Syed AS, Khan K, et al
    Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer.
    Brachytherapy. 2023 Oct 7:S1538-4721(23)01631.
    PubMed    
    Abstract available

  134. AYANTO SY, Belachew Lema T, Wordofa MA
    Women's and health professionals' perceptions, beliefs and barriers to cervical cancer screening uptake in Southern Ethiopia: a qualitative study.
    Sex Reprod Health Matters. 2023;31:2258477.
    PubMed    
    Abstract available

  135. CHEN R, Fang T, Liu N, Shi X, et al
    Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway.
    Naunyn Schmiedebergs Arch Pharmacol. 2023 Oct 9. doi: 10.1007/s00210-023-02757.
    PubMed    
    Abstract available

  136. IMAGING CMM
    Retracted: Investigation of the Clinical Application Value of HR-HPV DNA Combined with Liquid Based Cytology in Colposcopy of Cervical Cancer.
    Contrast Media Mol Imaging. 2023;2023:9891864.
    PubMed    
    Abstract available

  137. LE BIHAN-BENJAMIN C, Audiger C, Khati I, de Bels F, et al
    Cervical cancer screening pathways in France in 2015-2021, a nationwide study based on medico-administrative data.
    Prev Med Rep. 2023;36:102429.
    PubMed    
    Abstract available

  138. WEI HF, Zhang RF, Zhao YC, Tong XS, et al
    SERPINB7 as a prognostic biomarker in cervical cancer: Association with immune infiltration and facilitation of the malignant phenotype.
    Heliyon. 2023;9:e20184.
    PubMed    
    Abstract available

  139. PATEL D, Tayade S, Tidke VP, Toshniwal S, et al
    Radiotherapy Versus Chemotherapy in Locally Advanced Cervical Cancer.
    Cureus. 2023;15:e44726.
    PubMed    
    Abstract available

  140. ALSHARIF F, Ibrahim F, Alotaibi M, Khalaf M, et al
    The Relationship Between Knowledge and Practice of Postreproductive Women Toward Prevention and Screening of Breast and Cervical Cancer in Saudi Arabia.
    Cureus. 2023;15:e44858.
    PubMed    
    Abstract available

  141. HENES M, Mann E, Hirchenhain C, Bauer E, et al
    Registry Study of the Working Group on Cervical Pathology and Colposcopy (AGCPC) on the Diagnostic Algorithm for the New Cervical Cancer Screening - Initial Data.
    Geburtshilfe Frauenheilkd. 2023;83:1250-1262.
    PubMed    
    Abstract available

  142. FEHM T, Beckmann MW, Mahner S, Denschlag D, et al
    Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Surgical Therapy for Patients with Stage IA2-IIB1 Cervical Cancer.
    Geburtshilfe Frauenheilkd. 2023;83:1199-1204.
    PubMed    
    Abstract available

  143. LV X, Jia Y, Li J, Deng S, et al
    The construction of a prognostic model of cervical cancer based on four immune-related LncRNAs and an exploration of the correlations between the model and oxidative stress.
    Front Pharmacol. 2023;14:1234181.
    PubMed    
    Abstract available

  144. ZHU X, Song X, Chen Q, Peng Y, et al
    The prognostic, immunological and single-cell features of m6A molecules in cervical cancer.
    Cell Mol Biol (Noisy-le-grand). 2023;69:89-99.
    PubMed    
    Abstract available

  145. WANG X, Xu J, Hua F, Wang Y, et al
    MiR-214-3p suppresses cervical cancer cell metastasis by downregulating THBS2.
    Cell Mol Biol (Noisy-le-grand). 2023;69:195-200.
    PubMed    
    Abstract available

  146. GHOSH S, Saha R, Sarkar S, Biswas A, et al
    Rhodamine hydrazide-linked naphthalimide derivative: Selective naked eye detection of Cu(2+), S(2-) and understanding the therapeutic potential of the copper complex as an anti-cervical cancer agent.
    Spectrochim Acta A Mol Biomol Spectrosc. 2023;305:123428.
    PubMed    
    Abstract available

  147. DOZIE UW, Ezeala OV, David CI, Dozie KCN, et al
    Factors associated with health seeking delay in the screening of cervical cancer among women in Imo state, south Eastern Nigeria.
    Cancer Treat Res Commun. 2023;37:100765.
    PubMed    
    Abstract available

  148. LUO Q, Zeng X, Luo H, Pan L, et al
    Epidemiologic characteristics of high-risk HPV and the correlation between multiple infections and cervical lesions.
    BMC Infect Dis. 2023;23:667.
    PubMed    
    Abstract available

  149. MODABBER N, Mahboub SS, Khoshravesh S, Karimpour F, et al
    Evaluation of Long Non-coding RNA (LncRNA) in the Pathogenesis of Chemotherapy Resistance in Cervical Cancer: Diagnostic and Prognostic Approach.
    Mol Biotechnol. 2023 Oct 7. doi: 10.1007/s12033-023-00909.
    PubMed    
    Abstract available

  150. PAK K, Yoon HJ
    Impact of 18F-FDG PET on the Management in Patients With Recurrent Gynecologic cancer: A Meta-analysis.
    Clin Nucl Med. 2023 Sep 19. doi: 10.1097/RLU.0000000000004839.
    PubMed    
    Abstract available

  151. YOSHINO Y, Yanai S, Sawada M, Sakate S, et al
    Extraovarian Dysgerminoma Involving the Uterine Cervix: A Rare Case Report With Literature Review.
    Int J Gynecol Pathol. 2023;42:544-549.
    PubMed    
    Abstract available

  152. ELBANNA M, Pynda Y, Kalinchuk O, Rosa A, et al
    Radiotherapy resources in Latin America and the Caribbean: a review of current and projected needs based on International Atomic Energy Agency data.
    Lancet Oncol. 2023;24:e376-e384.
    PubMed    
    Abstract available

  153. HA Y, Lee K, Park B, Suh M, et al
    Parental intention to vaccinate daughters with the human papillomavirus vaccine in Korea: a nationwide cross-sectional survey.
    Epidemiol Health. 2023;45:e2023076.
    PubMed    
    Abstract available

  154. MONSRUD AL, Avadhani V, Mosunjac MB, Flowers L, et al
    Programmed Death Ligand-1 (PD-L1) Expression in Cervical Squamous Cell Carcinoma: Does it Correlate With Outcomes?
    Int J Gynecol Pathol. 2023;42:535-543.
    PubMed    
    Abstract available

  155. BOGANI G, Sopracordevole F, Ciavattini A, Vizza E, et al
    Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia.
    Eur J Cancer Prev. 2023;32:525-532.
    PubMed    
    Abstract available

  156. ZHANG H, Zhang R, Su Y, Zheng J, et al
    Anti-cervical cancer mechanism of bioactive compounds from Alangium platanifolium based on the 'compound-target-disease' network.
    Heliyon. 2023;9:e20747.
    PubMed    
    Abstract available

  157. HEALTHCARE ENGINEERING JO
    Retracted: Functional New Transcription Factors (TFs) Associated with Cervical Cancer.
    J Healthc Eng. 2023;2023:9835459.
    PubMed    
    Abstract available

  158. HEALTHCARE ENGINEERING JO
    Retracted: A Research Study to Measure the Efficacy of Terminating Cervical Cancer via Customized Optimum Pathway.
    J Healthc Eng. 2023;2023:9840958.
    PubMed    
    Abstract available

  159. KANAO H, Kanno M, Fusegi A, Aoki Y, et al
    Transperineal endoscopic approach with GelPOINT V-path in laparoscopic pelvic exenteration for postirradiated recurrent cervical cancer.
    Gynecol Oncol Rep. 2023;50:101291.
    PubMed    
    Abstract available

  160. BAI Y, Wang W, Cheng Y, Yang Y, et al
    Research progress on the GRP78 gene in the diagnosis, treatment and immunity of cervical cancer.
    Eur J Med Res. 2023;28:447.
    PubMed    
    Abstract available

  161. LI F, Mei F, Yin S, Du Y, et al
    Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor.
    J Gynecol Oncol. 2023 Sep 26. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  162. HWANG JH, Kim B
    Comparison of survival outcomes between robotic and laparoscopic radical hysterectomies for early-stage cervical cancer: a systemic review and meta-analysis.
    J Gynecol Oncol. 2023 Sep 25. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  163. SUN S, Wang Y, Liu Y, Leng Z, et al
    Telomerase reverse transcriptase gene polymorphisms and cervical cancer susceptibility in high-risk human papillomavirus-infected women.
    J Obstet Gynaecol Res. 2023 Oct 19. doi: 10.1111/jog.15815.
    PubMed    
    Abstract available

  164. DAMGACIOGLU H, Burus T, Sonawane K, Hill E, et al
    County-Level Trends in Cervical Cancer Incidence, Stage at Diagnosis, and Mortality in Kentucky.
    JAMA Netw Open. 2023;6:e2338333.
    PubMed    


  165. BONLOKKE S, Steiniche T, Sorensen BS, Nyvang GB, et al
    Circulating cell-free HPV DNA is a strong marker for disease severity in cervical cancer.
    Mol Oncol. 2023 Oct 19. doi: 10.1002/1878-0261.13538.
    PubMed    
    Abstract available

  166. DAI Y, Zhang Y, Ke X, Liu Y, et al
    Cutaneous metastasis from cervical cancer to the scalp and trunk: a case report and review of the literature.
    J Med Case Rep. 2023;17:435.
    PubMed    
    Abstract available

  167. LI Z, Chen S, Mahjabeen I, Shafique R, et al
    Nurses and doctors 's awareness and knowledge towards treatment and care of cervical cancer patients: a cross-sectional study.
    BMC Nurs. 2023;22:389.
    PubMed    
    Abstract available

  168. CHEN X, Shi W, Wang C, Zhu H, et al
    Personalized prognostic prediction tool for high-grade neuroendocrine cervical cancer: a SEER database analysis and single-center validation.
    J Cancer Res Clin Oncol. 2023 Oct 18. doi: 10.1007/s00432-023-05414.
    PubMed    
    Abstract available

  169. HUANG J, Tan Z, Wu W, Wu X, et al
    Effect of robotic versus laparoscopic surgery on postoperative wound infection in patients with cervical cancer: A meta-analysis.
    Int Wound J. 2023 Oct 18. doi: 10.1111/iwj.14437.
    PubMed    
    Abstract available

  170. SHI YY, Dong DR, Fan G, Dai MY, et al
    A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.
    Front Immunol. 2023;14:1237964.
    PubMed    
    Abstract available

  171. AMINI-FARSANI Z, Hashemi Sheikhshabani S, Shaygan N, Asgharzade S, et al
    The impact of oleuropein on miRNAs regulating cell death signaling pathway in human cervical cancer cells.
    Biotechnol Appl Biochem. 2023 Oct 17. doi: 10.1002/bab.2521.
    PubMed    
    Abstract available

  172. YANG X, Sun F, Gao Y, Li M, et al
    Histone acetyltransferase CSRP2BP promotes the epithelial-mesenchymal transition and metastasis of cervical cancer cells by activating N-cadherin.
    J Exp Clin Cancer Res. 2023;42:268.
    PubMed    
    Abstract available

  173. ASARE M, Obiri-Yeboah D, Enyan NIE, Nuer-Allornuvor G, et al
    An intervention to increase cervical cancer screening among women living with HIV: A mixed methods study.
    Patient Educ Couns. 2023;118:107993.
    PubMed    
    Abstract available

  174. HUANG J, Wei W, Kang F, Tan S, et al
    ANXA3, associated with YAP1 regulation, participates in the proliferation and chemoresistance of cervical cancer cells.
    Genes Genomics. 2023 Oct 16. doi: 10.1007/s13258-023-01461.
    PubMed    
    Abstract available

  175. KULHAN M, Bilgi A, Avci F, Ucar MG, et al
    Is HPV-negative cervical carcinoma a different type of cervical cancer?
    Eur Rev Med Pharmacol Sci. 2023;27:9205-9212.
    PubMed    
    Abstract available

  176. VIMPERE L, Sami J, Jeannot E
    Cervical cancer screening programs for female sex workers: a scoping review.
    Front Public Health. 2023;11:1226779.
    PubMed    
    Abstract available

  177. WAGNER-LARSEN KS, Hodneland E, Fasmer KE, Lura N, et al
    MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.
    Cancer Med. 2023 Oct 16. doi: 10.1002/cam4.6526.
    PubMed    
    Abstract available

  178. SHARMA CP, Vyas A, Pandey P, Gupta S, et al
    A new class of teraryl-based AIEgen for highly selective imaging of intracellular lipid droplets and its detection in advanced-stage human cervical cancer tissues.
    J Mater Chem B. 2023 Oct 16. doi: 10.1039/d3tb01764.
    PubMed    
    Abstract available

  179. LV Z, Wang YY, Wang YW, He JJ, et al
    A meta-analysis of treatment for early-stage cervical cancer: open versus minimally invasive radical trachelectomy.
    BMC Pregnancy Childbirth. 2023;23:727.
    PubMed    
    Abstract available

  180. CHIAPPA V, Bogani G, Interlenghi M, Vittori Antisari G, et al
    Using Radiomics and Machine Learning Applied to MRI to Predict Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.
    Diagnostics (Basel). 2023;13:3139.
    PubMed    
    Abstract available

  181. LEE YM, Lee B, Cho NH, Park JH, et al
    Beyond the Microscope: A Technological Overture for Cervical Cancer Detection.
    Diagnostics (Basel). 2023;13:3079.
    PubMed    
    Abstract available

  182. WASHINGTON B, Cheek D, Fabian D, Kudrimoti M, et al
    Effects of Interfraction Dose Variations of Target and Organs at Risk on Clinical Outcomes in High Dose Rate Brachytherapy for Cervical Cancer.
    Cancers (Basel). 2023;15:4862.
    PubMed    
    Abstract available

  183. PACHE B, Tantari M, Guani B, Mathevet P, et al
    Predictors of Non-Sentinel Lymph Node Metastasis in Patients with Positive Sentinel Lymph Node in Early-Stage Cervical Cancer: A SENTICOL GROUP Study.
    Cancers (Basel). 2023;15:4737.
    PubMed    
    Abstract available

  184. ALSHAMI I, Alattas RO, Waad A A, Anwar A S, et al
    Role of T cells in cervical cancer.
    Bioinformation. 2023;19:556-561.
    PubMed    
    Abstract available

  185. LU Q, Lao X, Gan J, Du P, et al
    Impact of NLRP3 gene polymorphisms (rs10754558 and rs10733113) on HPV infection and cervical cancer in southern Chinese population.
    Infect Agent Cancer. 2023;18:64.
    PubMed    
    Abstract available

  186. ZHAO M, Zhang X, Huan Q, Dong M, et al
    Metabolism-associated molecular classification of cervical cancer.
    BMC Womens Health. 2023;23:555.
    PubMed    
    Abstract available

  187. XU J, Xue B, Gong M, Ling L, et al
    circ_0000337 Promotes the Progression of Cervical Cancer by miR-155-5p/RAB3B Axis.
    Biochem Genet. 2023 Oct 26. doi: 10.1007/s10528-023-10534.
    PubMed    
    Abstract available

  188. MAROGA N, Mokoena T, Ledibane N, Musekiwa A, et al
    Profile of human papillomavirus genotypes in breast and oesophageal cancer patients in Pretoria, South Africa.
    S Afr Med J. 2023;113:49-54.
    PubMed    
    Abstract available

  189. KHAN A
    Role of human papillomavirus (HPV) in cancers.
    S Afr Med J. 2023;113:10.
    PubMed    



  190. LncRNA SNHG7 Functions as an Oncogene in Cervical Cancer by Sponging miR-485-5p to Modulate JUND Expression [Retraction].
    Onco Targets Ther. 2023;16:847-848.
    PubMed    
    Abstract available

  191. FUNDERUD M, Hoem IS, Guleng MAD, Eidem M, et al
    Script-based automatic radiotherapy planning for cervical cancer.
    Acta Oncol. 2023 Oct 25:1-10. doi: 10.1080/0284186X.2023.2267171.
    PubMed    
    Abstract available

  192. ASHIQUE S, Faruk A, Ahmad FJ, Khan T, et al
    It Is All about Probiotics to Control Cervical Cancer.
    Probiotics Antimicrob Proteins. 2023 Oct 25. doi: 10.1007/s12602-023-10183.
    PubMed    
    Abstract available

  193. SASIVIMOLRATTANA T, Chaiwongkot A, Bhattarakosol P
    HPV16E1 downregulation altered the cell characteristics involved in cervical cancer development.
    Sci Rep. 2023;13:18217.
    PubMed    
    Abstract available

  194. SAHSUVAR S, Guner R, Gok O, Can O, et al
    Development and pharmaceutical investigation of novel cervical cancer-targeting and redox-responsive melittin conjugates.
    Sci Rep. 2023;13:18225.
    PubMed    
    Abstract available

  195. IBRAHIM KHALIL A, Zhang L, Muwonge R, Sauvaget C, et al
    Efficacy and safety of therapeutic HPV vaccines to treat CIN 2/CIN 3 lesions: a systematic review and meta-analysis of phase II/III clinical trials.
    BMJ Open. 2023;13:e069616.
    PubMed    
    Abstract available

  196. SILVA GAE, Damacena GN, Ribeiro CM, Alcantara LLM, et al
    Papanicolaou test in Brazil: analysis of the National Health Survey of 2013 and 2019.
    Rev Saude Publica. 2023;57:55.
    PubMed    
    Abstract available

  197. ASWATHY R, Sumathi S
    Defining new biomarkers for overcoming therapeutical resistance in cervical cancer using lncRNA.
    Mol Biol Rep. 2023 Oct 25. doi: 10.1007/s11033-023-08864.
    PubMed    
    Abstract available

  198. SUN X, Ye G, Li J, Shou H, et al
    Parkin regulates IGF2BP3 through ubiquitination in the tumourigenesis of cervical cancer.
    Clin Transl Med. 2023;13:e1457.
    PubMed    
    Abstract available

  199. LI J, Huang L, Wu H, Li J, et al
    Re-irradiation for recurrent cervical cancer: A single institutional experience.
    Clin Transl Radiat Oncol. 2023;43:100690.
    PubMed    
    Abstract available

  200. WANG X, Xu J, Zhang H, Qu P, et al
    The effect of albumin and hemoglobin levels on the prognosis of early-stage cervical cancer: a prospective, single-center-based cohort study.
    BMC Womens Health. 2023;23:553.
    PubMed    
    Abstract available

  201. TIAN J, Wang N, Wang C, Wu DP, et al
    [Hsa_circ_0000392 affects the radiation sensitivity of cervical cancer by targeting the miR-145-5p/CRKL/MAPK pathway].
    Zhonghua Zhong Liu Za Zhi. 2023;45:879-891.
    PubMed    
    Abstract available

  202. BRANDFORD AA, Williams EN, Han G, Weston C, et al
    Adverse Childhood Experiences and Preventive Cervical Cancer Screening Behavior.
    Oncol Nurs Forum. 2023;50:679-691.
    PubMed    
    Abstract available

  203. CRAFTON SM, Venkat PS, Salani R
    A review of the state of cervical cancer: updates from prevention to recurrent disease.
    Curr Opin Obstet Gynecol. 2023 Oct 12. doi: 10.1097/GCO.0000000000000918.
    PubMed    
    Abstract available

  204. DESPOT A, Fures R, Despot AM, Mikus M, et al
    Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development?
    Open Med (Wars). 2023;18:20230826.
    PubMed    
    Abstract available

  205. GASHU C, Aguade AE
    Predictors of cervical tumour size for outpatients with cervical cancer at the University of Gondar referral hospital: a retrospective study design.
    Eur J Med Res. 2023;28:453.
    PubMed    
    Abstract available

  206. DING S, Wang H, Liao Y, Chen R, et al
    HPV16 E7 protein antagonizes TNF-alpha-induced apoptosis of cervical cancer cells via Daxx/JNK pathway.
    Microb Pathog. 2023;185:106423.
    PubMed    
    Abstract available

  207. GIUDICE E, Mirza MR, Lorusso D
    Advances in the Management of Recurrent Cervical Cancer: State of the Art and Future Perspectives.
    Curr Oncol Rep. 2023 Oct 23. doi: 10.1007/s11912-023-01463.
    PubMed    
    Abstract available

  208. SCHITCU VH, Marica NA, Borz MB
    3D Laparoscopic Ureterolysis for Retroperitoneal Fibrosis Secondary to Radical Hysterectomy and Radiation Treatment for Cervical Cancer: Results from the Oncological Institute, Cluj Napoca.
    Arch Esp Urol. 2023;76:519-524.
    PubMed    
    Abstract available

  209. WANG M, Liu J, Liao X, Yi Y, et al
    The SGK3-Catalase antioxidant signaling axis drives cervical cancer growth and therapy resistance.
    Redox Biol. 2023;67:102931.
    PubMed    
    Abstract available

  210. IKOMA T, Kato T, Okada K, Takama N, et al
    Right ventricular metastasis of cervical cancer visualized on transthoracic echocardiography: the importance of the "modified off-axis right ventricular apical 4-chamber view".
    J Med Ultrason (2001). 2023 Oct 21. doi: 10.1007/s10396-023-01372.
    PubMed    


  211. SWANSON AA, Pantanowitz L
    The evolution of cervical cancer screening.
    J Am Soc Cytopathol. 2023 Sep 25:S2213-2945(23)00229.
    PubMed    
    Abstract available

  212. ALSHEHRI MA, Asiri SA, Alzahrani A, Alazragi RS, et al
    Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\GBSA and MD simulation study.
    Med Oncol. 2023;40:337.
    PubMed    
    Abstract available

  213. CORRADO G, Anchora LP, Bruni S, Sperduti I, et al
    Patterns of recurrence in FIGO stage IB1-IB2 cervical cancer: Comparison between minimally invasive and abdominal radical hysterectomy.
    Eur J Surg Oncol. 2023;49:107047.
    PubMed    
    Abstract available

  214. WANG Y, Sun Y, Gan K, Yuan J, et al
    Bone marrow sparing oriented multi-model image registration in cervical cancer radiotherapy.
    Comput Biol Med. 2023;166:107581.
    PubMed    
    Abstract available

  215. REYNDERS C, Lerho T, Goebel EA, Crum CP, et al
    Prevalence and genotype distribution of human papillomavirus in cervical adenocarcinoma (usual type and variants): A systematic review and meta-analysis.
    J Med Virol. 2023;95:e29190.
    PubMed    
    Abstract available

  216. WANG MY, Cun YN
    [Current status of clinical trials of HPV therapeutic vaccines].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2023;57:1647-1654.
    PubMed    
    Abstract available

  217. LE A, Rohweder C, Wheeler SB, Lafata JE, et al
    Self-Collection for Primary HPV Testing: Perspectives on Implementation From Federally Qualified Health Centers.
    Prev Chronic Dis. 2023;20:E93.
    PubMed    
    Abstract available

  218. BARTHOLOMEW K, Aye PS, Griffiths V, Schaapveld T, et al
    Retrospective survey of colposcopy experience for wahine Maori across two time periods (2016 and 2021) in Waitemata and Auckland districts, New Zealand.
    N Z Med J. 2023;136:10-26.
    PubMed    
    Abstract available

  219. HOCHMANN J, Millan M, Hernandez P, Lafon-Hughes L, et al
    Contributions of viral oncogenes of HPV-18 and hypoxia to oxidative stress and genetic damage in human keratinocytes.
    Sci Rep. 2023;13:17734.
    PubMed    
    Abstract available

  220. BAENA A, Paolino M, Villarreal-Garza C, Torres G, et al
    Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening.
    Cancer Epidemiol. 2023;86 Suppl 1:102446.
    PubMed    
    Abstract available

  221. XIE S, Huang R, Zhan Y, Cai Q, et al
    Efficacy of fosaprepitant combined with tropisetron plus dexamethasone in preventing nausea and emesis during fractionated radiotherapy with weekly cisplatin chemotherapy: interim analysis of a randomized, prospective, clinical trial using competing r
    Support Care Cancer. 2023;31:640.
    PubMed    
    Abstract available

  222. CHEN LM, Cong Q, Wu D, Chen Y, et al
    A prospective multicentre controlled study of Gaoweikang (Chinese multiherb extract-based tincture) used in high-risk HPV infections.
    Eur Rev Med Pharmacol Sci. 2023;27:8985-8992.
    PubMed    
    Abstract available

  223. LIU X, Wallace N
    HPV and HPV-associated cancer.
    J Med Virol. 2023;95:e29177.
    PubMed    


  224. COSMAS NT, Nimzing L, Egah DZ, Famooto OA, et al
    Dataset for vaginal human papillomavirus infection among adolescent and early adult girls in Jos, Nigeria.
    BMC Res Notes. 2023;16:272.
    PubMed    
    Abstract available

  225. ZHOU YX, Wang L, Wang TT, Qu XL, et al
    Analysis of HPV prevalence among individuals with reproductive tract infections in a Chinese population.
    Medicine (Baltimore). 2023;102:e34989.
    PubMed    
    Abstract available

  226. CHECCHI M, Mesher D, Panwar K, Anderson A, et al
    The impact of over ten years of HPV vaccination in England: Surveillance of type-specific HPV in young sexually active females.
    Vaccine. 2023 Oct 9:S0264-410X(23)01162-3. doi: 10.1016/j.vaccine.2023.
    PubMed    
    Abstract available

  227. YAN C, Ma Y, Li J, Chen X, et al
    Identification of key immune cell-related genes involved in tumorigenesis and prognosis of cervical squamous cell carcinoma.
    Hum Vaccin Immunother. 2023;19:2254239.
    PubMed    
    Abstract available

  228. FRICK C, Rumgay H, Vignat J, Ginsburg O, et al
    Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study.
    Lancet Glob Health. 2023;11:e1700-e1712.
    PubMed    
    Abstract available

  229. MONTI E, Matozzo CMM, Cetera GE, DI Loreto E, et al
    Correlation Between Colposcopic Patterns and Histological Grade of Vaginal Intraepithelial Neoplasia: A Retrospective Cohort Study.
    Anticancer Res. 2023;43:4637-4642.
    PubMed    
    Abstract available

  230. XIN Z, Yan W, Feng Y, Yunzhi L, et al
    An MRI-based machine learning radiomics can predict short-term response to neoadjuvant chemotherapy in patients with cervical squamous cell carcinoma: A multicenter study.
    Cancer Med. 2023;12:19383-19393.
    PubMed    
    Abstract available

  231. MOSQUERA I, Barajas CB, Zhang L, Lucas E, et al
    Assessment of organization of cervical and breast cancer screening programmes in the Latin American and the Caribbean states: The CanScreen5 framework.
    Cancer Med. 2023;12:19935-19948.
    PubMed    
    Abstract available

  232. BARTEMES KR, Gochanour BR, Routman DM, Ma DJ, et al
    Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
    Oral Oncol. 2023;146:106568.
    PubMed    
    Abstract available

  233. REUSCHENBACH M, Doorbar J, Del Pino M, Joura EA, et al
    Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer.
    Vaccine. 2023 Sep 11:S0264-410X(23)00990-8. doi: 10.1016/j.vaccine.2023.
    PubMed    
    Abstract available

  234. DUTTA P, Pal D, Roy A, Mandal RK, et al
    Role of MLH1 and MSH2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications.
    Gene. 2023;888:147746.
    PubMed    
    Abstract available

  235. HOPFENSPERGER KM, Adams QE, Kim Y, Wu X, et al
    The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
    Med Phys. 2023;50:6469-6478.
    PubMed    
    Abstract available

  236. MAO Z, Deng A, Jin X, Li M, et al
    A microfluidic-chip-based system with loop-mediated isothermal amplification for rapid and parallel detection of Trichomonas vaginalis and human papillomavirus.
    Analyst. 2023;148:4820-4828.
    PubMed    
    Abstract available

  237. YU L, Gao Z, Li Z, Liu P, et al
    Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
    J Cancer Res Clin Oncol. 2023;149:14673-14689.
    PubMed    
    Abstract available

  238. WANG N, Li X, Liu X, Bian M, et al
    Clinical Efficacy and Safety of AdV-tk Gene Therapy for Patients with Cervical Squamous Intraepithelial Lesion: A Prospective Study.
    Hum Gene Ther. 2023;34.
    PubMed    
    Abstract available

  239. YETIK I, Tanoglu FB, Pasin O, Cetin C, et al
    Knowledge levels and community guidance of doctors working in family health centers on HPV screening and HPV vaccination.
    J Obstet Gynaecol Res. 2023;49:2519-2527.
    PubMed    
    Abstract available

  240. LI X, Ling Y, Hu L, Zhang L, et al
    Detection of HPV DNA, E6/E7 mRNA, and p16INK4a in lung cancer: A systematic review and meta-analysis.
    J Infect Dis. 2023 Jul 28:jiad295. doi: 10.1093.
    PubMed    
    Abstract available

  241. JARADI B, Das T, Koo KM
    Design and Analytical Evaluation of a Rapid Plasma Screening Assay for Circulating Human Papillomavirus DNA via Thermostable Enzyme Chemistries.
    Anal Chem. 2023;95:11172-11180.
    PubMed    
    Abstract available

  242. NOFAL A, Nofal H, Alwirshiffani E, ElGhareeb MI, et al
    Treatment response and tolerability of intralesional quadrivalent versus bivalent human papillomavirus vaccine for recalcitrant warts: A randomized controlled trial.
    J Am Acad Dermatol. 2023;89:1051-1052.
    PubMed    


  243. RAIS M, Ouyahia A, Mohammedi D, Sadouki N, et al
    First study of genital HPV infection among women living with HIV recruited from May to September 2018 in Eastern Algeria.
    Int J STD AIDS. 2023 Jun 28:9564624231179274. doi: 10.1177/09564624231179274.
    PubMed    
    Abstract available

  244. SANO Y, Yoshida K, Hibi E, Sekiya A, et al
    A rare case of signet ring cell carcinoma with diffuse cutaneous systemic sclerosis: A case report.
    J Obstet Gynaecol Res. 2023;49:2549-2552.
    PubMed    
    Abstract available

  245. KISHIGAMI Y, Nakamura M, Nakao M, Okamoto H, et al
    Three-dimensional assessment of interfractional cervical and uterine motions using daily magnetic resonance images to determine margins and timing of replanning.
    J Appl Clin Med Phys. 2023;24:e14073.
    PubMed    
    Abstract available

  246. LOFTERS A, Prakash V, Devotta K, Vahabi M, et al
    The potential benefits of "community champions" in the healthcare system.
    Healthc Manage Forum. 2023;36:382-387.
    PubMed    
    Abstract available

  247. SMITH J, Dodd RH, Gainey KM, Naganathan V, et al
    Factors Influencing Primary Care Practitioners' Cancer Screening Recommendations for Older Adults: a Systematic Review.
    J Gen Intern Med. 2023;38:2998-3020.
    PubMed    
    Abstract available

  248. CHEN F, Hsu Lin L, Hindi I, Sun W, et al
    HPV Cotesting of Unsatisfactory Papanicolaou Tests: Implications for Follow-up Intervals.
    Am J Clin Pathol. 2023;160:137-143.
    PubMed    
    Abstract available

  249. GOSBELL E, Panambalana A, Stephenson A, Vici C, et al
    Awareness and attitudes towards the revised National Cervical Screening Program amongst women in rural New South Wales: a cross-sectional study.
    Aust J Prim Health. 2023;29:471-479.
    PubMed    
    Abstract available

  250. MINALT N, Caldwell A, Yedlicka GM, Joseph S, et al
    Association of Intrauterine Device Use and Endometrial, Cervical, and Ovarian Cancer: an Expert Review.
    Am J Obstet Gynecol. 2023 Mar 29:S0002-9378(23)00224.
    PubMed    
    Abstract available

  251. SHIGEISHI H
    Association between human papillomavirus and oral cancer: a literature review.
    Int J Clin Oncol. 2023;28:982-989.
    PubMed    
    Abstract available

  252. VATTAI A, Kremer N, Meister S, Beyer S, et al
    Increase of the T-reg-recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia.
    J Cancer Res Clin Oncol. 2023;149:6613-6623.
    PubMed    
    Abstract available

  253. FELICELLI C, Strickland A, Wei JJ
    Primary HPV-Associated Enteric-Type Adenocarcinoma of Vagina: A Case Report.
    Int J Surg Pathol. 2023;31:1393-1397.
    PubMed    
    Abstract available

  254. WATANABE-GALLOWAY S, Ratnapradipa K, Subramanian R, Ramos A, et al
    Mobile Health (mHealth) Interventions to Increase Cancer Screening Rates in Hispanic/Latinx Populations: A Scoping Review.
    Health Promot Pract. 2023;24:1215-1229.
    PubMed    
    Abstract available

  255. KANEKO N, Nishino Y, Ito Y, Nakaya T, et al
    Association of Socioeconomic Status Assessed by Areal Deprivation With Cancer Incidence and Detection by Screening in Miyagi, Japan Between 2005 and 2010.
    J Epidemiol. 2023;33:521-530.
    PubMed    
    Abstract available

  256. KIMURA F, Ohshima K, Shirai K, Kanai R, et al
    Discriminant Analysis Using Gabor Filter Sets for Lobular Endocervical Glandular Hyperplasia: Numerical Interpretation of Nuclear Atypia by Gabor Filter Features.
    Acta Cytol. 2023;67:539-549.
    PubMed    
    Abstract available

  257. KIR G, Ozen S
    Histopathologic Follow-Up of Women with Inadequate ThinPrep Cervical Pap Tests and Positive High-Risk Human Papillomavirus Test Results.
    Acta Cytol. 2023;67:533-538.
    PubMed    
    Abstract available

  258. HELLSTEN C, Holmberg A, Astrom J, Forslund O, et al
    Cervical cancer in Region Skane, Sweden 2017-2020 after the implementation of primary HPV screening: A quality assurance audit.
    Acta Obstet Gynecol Scand. 2023 Oct 10. doi: 10.1111/aogs.14691.
    PubMed    
    Abstract available

  259. CUSCHIERI K, Palmer T, Graham C, Cameron R, et al
    The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland.
    Br J Cancer. 2023 Aug 10. doi: 10.1038/s41416-023-02386.
    PubMed    
    Abstract available

  260. VIEIRA-COIMBRA M, Nogueira-Martins N, Zadykowicz R, Gaspar HR, et al
    EBCOG position statement on Inequalities in screening for cervical and breast cancer.
    Eur J Obstet Gynecol Reprod Biol. 2023;289:217-218.
    PubMed    
    Abstract available

  261. VIEIRA-COIMBRA M, Nogueira-Martins N, Zadykowicz R, Rodrigues Gaspar H, et al
    Provision of screening services for cervical and breast cancer - A scientific study commissioned by the European Board & College of Obstetrics and Gynaecology (EBCOG).
    Eur J Obstet Gynecol Reprod Biol. 2023 Aug 30:S0301-2115(23)00691.
    PubMed    
    Abstract available

  262. GHELMAN F, Cristina Cruz Silva N, Cristina Brollo Soares L
    Relation between naked eye Swede score and the outcomes of atypias of undetermined significance.
    Eur J Obstet Gynecol Reprod Biol. 2023;289:158-162.
    PubMed    
    Abstract available

  263. BAETEN IGT, Hoogendam JP, Schreuder HWR, Jurgenliemk-Schulz IM, et al
    Introducing a novice surgeon to an experienced robotic gynaecological oncology team: An observational cohort study on the impact of a structured curriculum on outcomes of cervical cancer surgery.
    Gynecol Oncol. 2023;178:153-160.
    PubMed    
    Abstract available

  264. MORTON M, Haight PJ, Khadraoui W, Backes F, et al
    "More than a song and dance": Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTok.
    Gynecol Oncol. 2023;175:81-87.
    PubMed    
    Abstract available

  265. HOLM J, Gerke O, Vilstrup MH, Spasojevic D, et al
    Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
    Gynecol Oncol. 2022 Sep 28. pii: S0090-8258(22)01841.
    PubMed    
    Abstract available

  266. INTURRISI F, de Sanjose S, Desai KT, Dagnall C, et al
    A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.
    Int J Cancer. 2023 Sep 29. doi: 10.1002/ijc.34698.
    PubMed    
    Abstract available

  267. MUNGO C, Osongo CO, Ambaka J, Omoto J, et al
    Efficacy of thermal ablation for treatment of biopsy-confirmed high-grade cervical precancer among women living with HIV in Kenya.
    Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34737.
    PubMed    
    Abstract available


  268. Harald zur Hausen 1936-2023.
    Int J Cancer. 2023;153:1937-1939.
    PubMed    


  269. DICK S, Heideman DAM, Mom CH, Meijer CJLM, et al
    Methylation testing for the detection of recurrent cervical intraepithelial neoplasia.
    Int J Cancer. 2023;153:2011-2018.
    PubMed    
    Abstract available

  270. VARGAS-CARDONA HD, Rodriguez-Lopez M, Arrivillaga M, Vergara-Sanchez C, et al
    Artificial intelligence for cervical cancer screening: Scoping review, 2009-2022.
    Int J Gynaecol Obstet. 2023 Oct 9. doi: 10.1002/ijgo.15179.
    PubMed    
    Abstract available

  271. RAMESAN CK, Calvin JD, Thomas A, Fletcher J, et al
    Diagnostic study of human papillomavirus DNA detection in cervical and vaginal samples using the filter paper card.
    Int J Gynaecol Obstet. 2023;163:660-666.
    PubMed    
    Abstract available

  272. MBURU A, Shaffi AF
    Pathological pelvic fracture due to metastatic cervical cancer in a young immunosuppressed woman.
    Int J Gynecol Cancer. 2023 Oct 19:ijgc-2023-004479.
    PubMed    


  273. XIA L, Wang J, Wang C, Zhang Q, et al
    Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study.
    Int J Gynecol Cancer. 2023 Oct 24:ijgc-2023-004705.
    PubMed    
    Abstract available

  274. FRUMOVITZ M, Morani AC, Aziz A, Jhingran A, et al
    PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study.
    Int J Gynecol Cancer. 2023 Oct 24:ijgc-2023-004907.
    PubMed    
    Abstract available

  275. GHOSH DS, Gurram DL, Kumar DA, Mulye DG, et al
    Clinical implementation of 'plan of the day' strategy in definitive radiotherapy of cervical cancer: Online adaptation to address the challenge of organ filling reproducibility.
    Int J Radiat Oncol Biol Phys. 2023 Oct 8:S0360-3016(23)07956.
    PubMed    
    Abstract available

  276. BOITANO TKL, Kako T, Leath CA 3rd
    Improving Therapies for Cervical Cancer While Working Toward Eradication.
    Obstet Gynecol. 2023 Oct 12. doi: 10.1097/AOG.0000000000005413.
    PubMed    
    Abstract available

  277. VOLESKY-AVELLANEDA KD, Laurie C, Tsyruk-Romano O, El-Zein M, et al
    Human Papillomavirus Detectability and Cervical Cancer Prognosis: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023;142:1055-1067.
    PubMed    
    Abstract available

  278. NANDWANA D, Hawes K, Zuend CF, Pope R, et al
    Neovaginal Human Papillomavirus Prevalence in Transfeminine Individuals: A Systematic Review.
    Obstet Gynecol. 2023;142:296-306.
    PubMed    
    Abstract available

  279. INAYAMA Y, Takamatsu S, Hamanishi J, Mizuno K, et al
    Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023;142:307-318.
    PubMed    
    Abstract available

  280. SHAN M, Deng Y, Zou W, Fan S, et al
    Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis.
    BMC Cancer. 2023;23:905.
    PubMed    
    Abstract available

  281. WANG J, Huang J, Ding H, Ma J, et al
    Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
    BMC Cancer. 2023;23:929.
    PubMed    
    Abstract available

  282. ZAFAR S, Khan K, Badshah Y, Shahid K, et al
    Correction: Exploring the prognostic significance of PKCepsilon variants in cervical cancer.
    BMC Cancer. 2023;23:963.
    PubMed    


  283. MISGUN T, Demissie DB
    Knowledge, practice of cervical cancer screening and associated factors among women police members of Addis Ababa police commission Ethiopia.
    BMC Cancer. 2023;23:961.
    PubMed    
    Abstract available

  284. TSEGAYE K, Hagos A, Kindie H, Minyihun A, et al
    Evaluation of cervical cancer screening program in Gondar city administration public health facilities, Northwest Ethiopia, 2021: mixed method approach.
    BMC Cancer. 2023;23:1034.
    PubMed    
    Abstract available

  285. LV N, Zhao Y, Song Y, Ji M, et al
    Development of a sensitive droplet digital PCR according to the HPV infection specificity in Chinese population.
    BMC Cancer. 2023;23:1022.
    PubMed    
    Abstract available

  286. MANTULA F, Toefy Y
    Women and health providers' perspectives on male support for cervical cancer screening in Gwanda district, Zimbabwe.
    PLoS One. 2023;18:e0282931.
    PubMed    
    Abstract available

  287. IORDANISHVILI S, Metreveli T, Lipartia E, Gachechiladze K, et al
    The HPV-TP53-MALAT1 Axis: Unravelling interactions in cervical cancer development.
    PLoS One. 2023;18:e0291725.
    PubMed    
    Abstract available

  288. FERREIRA HNC, Capistrano GN, Morais TNB, Costa KTDS, et al
    Screening and hospitalization of breast and cervical cancer in Brazil from 2010 to 2022: A time-series study.
    PLoS One. 2023;18:e0278011.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;